AMSTERDAM, the Netherlands, December 12 /PRNewswire-FirstCall/ --
- Forty-five Prestigious Journals to be Launched on ScienceDirect in Response to Customer Demand
Elsevier, a leading publisher of scientific, technical and medical (STM) information, today announced that 45 French-language medical journals from Elsevier Masson will be available on ScienceDirect beginning January 3, 2008.
The titles, including Feuillets de Radiologie, Journal de Chirurgie and La Press Medicale, represent a wide range of high-quality journals and complement the 27 Editions Scientifique et Medicales Elsevier (ESME) titles already hosted on the platform. The importance of this content addition is two-fold: it is a response to growing customer demand in French-speaking territories for French-language content, and it furthers Elsevier's local-language publishing program, which is making a wealth of important content accessible globally.
"We are always striving to respond positively to customer requests and deliver the content that will help them in their research," said Jay Katzen, Managing Director, Academic & Government Products. "The addition of this world-class local-language content meets both of these objectives and ensures that ScienceDirect continues to remain a comprehensive and complete platform."
The 45 titles that will be added date from the early 19th and 20th centuries and have strong ties with some of the most revered French Societies including the French Society of Rheumatology, the French Society of Anaesthesiology and the French Society of Pediatrics. The variety of specialist coverage is notable, with journal subjects ranging from anaesthesiology to pharmacology.
All of the journals to be added consist of high-quality articles, reviews and case reports. In addition, a number of the journals include some abstracts and articles in English. Subscribers will benefit from the current (2008) articles as well as four years in backfiles.
The Elsevier Masson collection on ScienceDirect will evolve with new titles added each year through new launches and acquisitions. For more information on ScienceDirect and for a complete list of titles that will be added, please visit http://www.info.sciencedirect.com.
Over a quarter of the world's full text scientific, technical and medical (STM) articles - managed by renowned editors, written by respected authors and read by researchers from around the globe - are available in one place: ScienceDirect (http://www.sciencedirect.com).
Elsevier's extensive and unique full-text collection covers authoritative titles from the core scientific literature including high impact factor titles such as THE LANCET, Cell and Tetrahedron. Over eight million articles are available online, including Articles in Press which offer rapid access to recently accepted manuscripts. The critical mass of information available on ScienceDirect is unsurpassed. Coverage includes over 2,000 journals published by Elsevier and dynamic linking to journals from approximately 2,000 STM publishers through CrossRef. An expanding program of online major reference works, handbooks, book series and eBooks in all fields of science seamlessly interlinks with primary research referenced in journal articles.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, http://youtube.com/watch?v=Aj7f3B1VCYM such as ScienceDirect ( http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered
in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part
of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading
publisher and information provider. Operating in the science and medical,
legal, education and business-to-business sectors, Reed Elsevier provides
high-quality and flexible information solutions to users, with increasing
emphasis on the Internet as a means of delivery. Reed Elsevier's ticker
symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange)
+1-202-898-2000, ext. 117
Copyright©2007 PR Newswire.
All rights reserved